Suppr超能文献

相似文献

1
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures.
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3141-5. doi: 10.1073/pnas.0915130107. Epub 2010 Feb 1.
2
In vitro models for analysis of the hepatitis C virus life cycle.
Microbiol Immunol. 2012 Jan;56(1):1-9. doi: 10.1111/j.1348-0421.2011.00403.x.
3
Scalable spheroid model of human hepatocytes for hepatitis C infection and replication.
Mol Pharm. 2014 Jul 7;11(7):2106-14. doi: 10.1021/mp500063y. Epub 2014 May 6.
4
(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
Hepatology. 2012 Mar;55(3):720-9. doi: 10.1002/hep.24803.
5
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines.
Virology. 2013 Sep;444(1-2):1-11. doi: 10.1016/j.virol.2013.05.036. Epub 2013 Jun 16.
6
Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
J Hepatol. 2015 Mar;62(3):541-8. doi: 10.1016/j.jhep.2014.10.040. Epub 2014 Nov 4.
8
The J6JFH1 strain of hepatitis C virus infects human B-cells with low replication efficacy.
Viral Immunol. 2014 Aug;27(6):285-94. doi: 10.1089/vim.2013.0140. Epub 2014 May 22.
10
Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry.
Antiviral Res. 2015 Jun;118:139-47. doi: 10.1016/j.antiviral.2015.04.003. Epub 2015 Apr 9.

引用本文的文献

1
Applications and research trends in organoid based infectious disease models.
Sci Rep. 2025 Jul 12;15(1):25185. doi: 10.1038/s41598-025-07816-7.
2
Liver portal fibroblasts induce the functions of primary human hepatocytes in vitro.
Commun Biol. 2025 May 9;8(1):721. doi: 10.1038/s42003-025-08135-3.
3
Recent advances in liver-on-chips: Design, fabrication, and applications.
Smart Med. 2023 Feb 12;2(1):e20220010. doi: 10.1002/SMMD.20220010. eCollection 2023 Feb.
5
Physiomimetic In Vitro Human Models for Viral Infection in the Liver.
Semin Liver Dis. 2023 Feb;43(1):31-49. doi: 10.1055/a-1981-5944. Epub 2022 Nov 19.
6
Physiologically relevant microsystems to study viral infection in the human liver.
Front Microbiol. 2022 Sep 28;13:999366. doi: 10.3389/fmicb.2022.999366. eCollection 2022.
7
A vascularized model of the human liver mimics regenerative responses.
Proc Natl Acad Sci U S A. 2022 Jul 12;119(28):e2115867119. doi: 10.1073/pnas.2115867119. Epub 2022 Jun 28.
8
Modeling Hepatotropic Viral Infections: Cells vs. Animals.
Cells. 2021 Jul 8;10(7):1726. doi: 10.3390/cells10071726.
9
Emerging liver organoid platforms and technologies.
Cell Regen. 2021 Aug 3;10(1):27. doi: 10.1186/s13619-021-00089-1.
10
Latest impact of engineered human liver platforms on drug development.
APL Bioeng. 2021 Jul 16;5(3):031506. doi: 10.1063/5.0051765. eCollection 2021 Sep.

本文引用的文献

1
Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system.
Nat Biotechnol. 2010 Feb;28(2):167-71. doi: 10.1038/nbt.1604. Epub 2010 Jan 31.
2
Focal distribution of hepatitis C virus RNA in infected livers.
PLoS One. 2009 Aug 18;4(8):e6661. doi: 10.1371/journal.pone.0006661.
3
Visualizing hepatitis C virus infections in human liver by two-photon microscopy.
Gastroenterology. 2009 Oct;137(4):1448-58. doi: 10.1053/j.gastro.2009.07.050. Epub 2009 Jul 24.
4
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.
Nature. 2009 Feb 12;457(7231):882-6. doi: 10.1038/nature07684. Epub 2009 Jan 28.
6
Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo.
Hepatology. 2008 Dec;48(6):1761-8. doi: 10.1002/hep.22547.
9
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge.
Nat Med. 2008 Jan;14(1):25-7. doi: 10.1038/nm1698. Epub 2007 Dec 6.
10
Microscale culture of human liver cells for drug development.
Nat Biotechnol. 2008 Jan;26(1):120-6. doi: 10.1038/nbt1361. Epub 2007 Nov 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验